Loss of NF1 in melanoma confers sensitivity to SYK kinase inhibition. Abecunas C, Whitehead CE, Ziemke EK, Baumann DG, et al. Cancer Res 2022 Nov 21:CAN-22-0883. doi: 10.1158/0008-5472.CAN-22-0883.

Read + Share

Amedeo Smart

Independent Medical Education

Abecunas C, Whitehead CE, Ziemke EK, Baumann DG, et al. Loss of NF1 in melanoma confers sensitivity to SYK kinase inhibition. Cancer Res 2022 Nov 21:CAN-22-0883. doi: 10.1158/0008-5472.CAN-22-0883.
PMID: 36409827